Gold-Induced Autoimmune Reactions

  • Timo Palosuo
  • Felix Milgrom


Despite widespread clinical use of gold in the treatment of rheumatoid arthritis (RA) for over 50 years (Anon, 1979), little is known about the mechanism of the therapeutic action of gold and of its toxicity. The efficacy of gold in RA has been well documented, and despite its occasionally serious side effects, such as proteinuria, nephrotic syndrome, exfoliative dermatitis, aplastic anemia, agranulocytosis, and thrombocytopenic purpura, gold is today accepted in most countries as a first-line treatment for RA. In the 1970s gold salts were also introduced and successfully used in the treatment of pemphigus (Penneys et al., 1973).


Rheumatoid Arthritis Rheumatoid Arthritis Patient Aplastic Anemia Gold Salt Membranous Glomerulonephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anon, 1979, Fifty years of gold in rheumatoid arthritis, Br. Med. J. 1:289.Google Scholar
  2. Davies, D. J., Dowling, J., and Xipell, J. M., 1977, Gold nephropathy, Pathology 9:281.CrossRefGoogle Scholar
  3. Forestier, J., 1935, Rheumatoid arthritis and its treatment by gold salts, J. Lab. Clin. Med. 20:827.Google Scholar
  4. Hurd, E. R., 1977, Drugs affecting the immune response, in: Immunology in Medicine (E. J. Holborow and W. G. Reeves, eds.), Academic Press, London, p. 1080.Google Scholar
  5. Jellum, E., Aaseth, J., and Munthe, E., 1977, Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same? Proc. R. Soc. Med. 70(Suppl. 3):136.Google Scholar
  6. Kirby, J. D., Dieppe, P. A., Huskisson, E. C., and Smith, B., 1979, d-Penicillamine and immune complex deposition, Ann. Rheum. Dis. 38:344.CrossRefGoogle Scholar
  7. Milgrom, F., 1980, Antigens of vertebrate cells, tissues, and body fluids, Transpl. Proc. 12(suppl. 1):2.Google Scholar
  8. Milgrom, F., Campbell, W., and Andres, G. A., 1976, Antigen in immune complex nephritis, Immunology 30:277.Google Scholar
  9. O’Brien, W. M., 1980, Toxicity of d-penicillamine in rheumatoid arthritis Ann. Intern. Med. 92:120.Google Scholar
  10. Palosuo, T., and Milgrom, F., 1981, Appearance of dextrans and anti-dextran antibodies in human sera, Int. Arch. Allergy Appl. Immunol., 65:153.CrossRefGoogle Scholar
  11. Palosuo, T., Provost, T. T., and Milgrom, F., 1976a, Gold nephropathy: Serologic data suggesting an immune complex disease, Clin. Exp. Immunol. 25:311.Google Scholar
  12. Palosuo, T., Andres, G. A., and Milgrom, F., 1976b, A ubiquitous tissue antigen and its corresponding antibody in sera of patients with glomerulonephritides, Int. Arch. Allergy Appl. Immunol. 52:129.CrossRefGoogle Scholar
  13. Palosuo, T., Kajander, A., von Essen, R., and Milgrom, F., 1978, Precipitating autoantibody to a ubiquitous tissue antigen: Association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine, Clin. Immunol. Immunopathol. 10:355.CrossRefGoogle Scholar
  14. Penneys, N. S., Eaglstein, W. H., Indgin, S., and Frost, P., 1973, Gold sodium thiomalate treatment of pemphigus, Arch Dermatol. 108:56.CrossRefGoogle Scholar
  15. Russel, A. S., and Lindstrom, J. M., 1978, Penicillamine-induced myasthenia gravis associated with antibodies to acetyl-choline receptor, Neurology 28:847.CrossRefGoogle Scholar
  16. Smith, W., and Ball, G. V., 1980, Lung injury due to gold treatment, Arth. Rheum. 23:351.CrossRefGoogle Scholar
  17. Törnroth, T., and Skrifvars, B., 1974, Gold nephropathy prototype of membranous glomerulonephritis, Am. J. Pathol. 75:573.Google Scholar
  18. Vernon-Roberts, B., Doré, J. L., Jessop, J. D., and Henderson, W. J., 1976, Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients, Ann. Rheum. Dis. 35:477.CrossRefGoogle Scholar
  19. Wooley, P. H., Griffin, J., Panayi, G. S., Batchelor, J. R., Welsh, K. I., and Gibson, T. J., 1980, HLA DR antigens and toxic reaction to sodium aurothiomalate and d-penicillamine in patients with rheumatoid arthritis, N. Engl. J. Med. 303:300.CrossRefGoogle Scholar
  20. Zilko, P. J., Dawkins, R. L., and Cohen, M. L., 1977, Penicillamine treatment of rheumatoid arthritis: Relationship of proteinuria and autoantibodies to immune status, Proc. R. Soc. Med. 70(Suppl. 3):118.Google Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Timo Palosuo
    • 1
    • 2
  • Felix Milgrom
    • 2
  1. 1.National Public Health InstituteHelsinkiFinland
  2. 2.Department of Microbiology, School of MedicineState University of New York at BuffaloBuffaloUSA

Personalised recommendations